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Abstract: Nanotechnology has wide applications in many fields, especially in the biological 
sciences and medicine. Nanomaterials are applied as coating materials or in treatment and 
diagnosis. Nanoparticles such as titania, zirconia, silver, diamonds, iron oxides, carbon nanotubes, 
and biodegradable polymers have been studied in diagnosis and treatment. Many of these 
nanoparticles may have toxic effects on cells. Many factors such as size, inherent properties, 
and surface chemistry may cause nanoparticle toxicity. There are methods for improving the 
performance and reducing toxicity of nanoparticles in medical design, such as biocompatible 
coating materials or biodegradable/biocompatible nanoparticles. Most metal oxide nanoparticles 
show toxic effects, but no toxic effects have been observed with biocompatible coatings. 
Biodegradable nanoparticles are also used in the efficient design of medical materials, which 
will be reviewed in this article.
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Introduction
The development of nanotechnology in different industries, its modernity, and also 
the lack of information on its negative effects on human health and the environment 
originate from the novel mechanisms that are also related to nanotoxicology. Some 
researchers are fundamentally against using nanomaterials in human medicine 
and in the environment while others are in favor. The important point here is that 
because there are many nanomaterials with many different uses, it is difficult 
to test all of them and estimate their effects on human health. Therefore, some 
scientists believe that their side effects are acceptable.1,2 Considering all factors,   
testing the effects of nanomaterials on mammals and the environment is necessary. 
Only with more research, and using scientific evidence, microscopy tools, and 
modern analysis methods, can we discover the advantages or disadvantages of 
their applications. New features of nano-sized materials can be found, including 
electrical conductivity, reactivity, stability, colorability, and toxicity.2 Carbon in the 
form of graphite is soft and malleable, although at a nano-sized scale, it becomes a 
nanocarbon tube, which is tougher than steel. One gram of catalyst with a diameter 
of 10 nm is about 100 times more reactive than a similar particle with a diameter of 
1 µm. However, toxicity occurs with nano- and micron-sized particles. The important 
fact about nanoparticles is their remarkable reactivity, a characteristic that may 
result in toxicity effects.1,2 In this review article, nanobiomaterials used in the field 
of medical sciences are discussed, along with their toxicity effects.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Nanotoxicology
Nanotoxicology is a branch of bionanoscience, which 
deals with the study and application of the toxicity 
of nanomaterials. Nanomaterials, even when made of 
inert elements such as gold, become highly active at 
nanometer dimensions. Nanotoxicological studies are used to   
determine whether and to what extent these properties may 
pose a threat to the environment and to human health.3
Nanoparticles play a remarkable role in toxicity, which is 
important for toxicologists, especially in respiratory diseases. 
Their size is an important factor in the occurrence of disease. 
Some studies on the different sizes of carbon and titanium 
oxide showed that reduction in nanoparticle size increases 
its toxicity in the lungs. Also notable is that combining some 
metals with each other causes complex toxicity, which does 
not occur with single metals. In 1975, a study showed the 
effect of oxidative stress caused by asbestos as the main 
factor in asbestosis and also in disturbing cell structure. 
In 1998, Zhang presented his findings on the effects of 
nanoparticles on respiratory toxicity and inflammation.4 
Some of the particle features such as size, surface chemistry, 
and oxidative stress functions play important roles in 
nanotoxicity. Other features such as crystallinity, coating, 
and the longevity of particles have also been studied as 
important parameters.5 By gaining control over dangerous 
particles, we can increase the use of nanoparticles by 
reducing their harmful effects, and thus allowing them to 
be used in the curing of diseases.5–9
Important factors
Size
For particle toxicity, two factors are important: size and 
chemical compounds. A reduction in the size of nano-sized 
particles results in an increase in particle surface area. 
Therefore more chemical molecules may attach to this 
surface, which would enhance its reactivity and result in an 
increase in its toxic effects.8,9 Many studies on the absorption 
of nanoparticles from the mucus have examined these effects. 
After absorption, nanoparticles reach the blood stream 
and then spread through the tissue. In one study, 33% of 
50 nm, 26% of 100 nm, and 10% of 500 nm particles were 
discovered in mucosal and lymphatic tissues of the intestine.9 
Nanoparticles larger than 1 µm were weakly observed and 
nanoparticles larger than 3 µm were occasionally seen in 
lymphatic tissues. Researchers have concluded that:
–	 Nanoparticles smaller than 100 nm are absorbed by the 
cells of the intestine but not the larger nanoparticles 
(300 nm).
–	 The absorption of smaller nanoparticles (100 nm) in the 
lymphatic tissue is greater than in intestinal cells.
–	 Intestinal cells cannot absorb nanoparticles larger than 
400 nm.
–	 Only nanoparticles smaller than 500 nm can enter the 
circulatory system.
Scientists are discussing the relationship between par-
ticle sizes and their penetration into mesenteric lymphatic 
glands, but so far have reached no agreement.9
In addition to being able to cross cell membranes, and 
reach the blood and various organs because of their small 
size, nanoparticles have a bigger surface to volume ratio than 
larger particles. Therefore more molecules of the chemical are 
present on the surface, which may be one of the reasons why 
nanoparticles are generally more toxic than larger particles 
of the same composition.9
Particle surface
In vitro studies have shown that very small particles have 
more pathological and destructive power on the lungs rather 
than the same particles of smaller size due to their larger 
surface area, greater tendency to conjugate, and energy 
sustainability.6–8,10–12
Surface chemistry
Geiser et al13 studied the interaction between particle 
surface chemistry and the lung’s surface-lining layer. 
They found that, regardless of the nature of the surface, 
the particles will be submersed into the lining layer 
after deposition in the small airways and alveoli. This 
displacement is promoted by the surfactant film itself 
as its surface tension falls temporarily to relatively low 
values.13,14 On the other hand, the reactive groups on a 
particle surface will certainly modify the biological effects. 
For silica, it has been shown that surface modification of 
the quartz affects its cytotoxicity, inflammogenicity, and 
fibrogenicity. These differences are mainly due to particle 
surface characteristics.15 The specific cytotoxicity of silica 
is strongly correlated with the appearance of surface 
radicals and reactive oxygen species (ROS), which is 
considered a key event in the development of fibrosis 
and lung cancer caused by this compound.16 Although the 
type of particle does not seem to play an important role 
in whether it is embedded in the surfactant lining of the 
alveoli, the embedding process itself is crucial. Particle–
cell interaction is possible only after the immersion of the 
particulates in the lining fluid, and research is needed to 
study this phenomenon in detail in relation to the inhaled International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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nanoparticles. Logically, as described in a report on 
silica,16 the reactive groups on nanoparticles influence 
their interaction with the lungs (or more generally with 
biological material). In some instances, it may be possible 
to predict the reactivity of the nanoparticle surface. The 
scarcity of data, however, suggests that verifying these 
predictions by laboratory testing would be sensible. The 
degree of hydrophobicity and hydrophilicity of a surface 
is the major feature used to estimate the toxicity. As well 
as size, it seems that the particle surface is critical in 
their absorption in the intestinal mucus. The absorption 
of nanoparticles produced by hydrophobic polymers is 
greater than that of nanoparticles produced by hydrophilic 
polymers.10–12
Chemical components
Chemical components of the particle surface have important 
effects on nanoparticles as they can react with metals. Iron can 
be affected by nanoparticles, which increases the induction 
of ROS in the free cell system. The surface modification 
of nanoparticles can reduce toxicity. Researchers have 
also shown that the toxicity of super paramagnetic iron 
oxide nanoparticles could be reduced by coating them with 
pullulan.10–12
Dosage
Toxicity and other responses depend on the prescribed dosage 
and substances used. Research has shown that a high dose 
of nanoparticles in small or big particles could be harmful 
to health.10–12
Free radical production
Most or all pathogenic particles produce free radicals in the 
free cell system and this ability causes oxidative stress, which 
gives rise to inflammation, cell destruction, and genotoxicity. 
The particle surface of free radicals can activate the redox 
cycle and cause particle toxicity.10,17
Passage of nanomaterials through 
tissues
In body engineering and design, there are three important 
sites in relation to the environment: skin, lungs, and the 
digestive tract. These organs protect the body from harmful 
environmental components. In other words, they are important 
organs in the transmission of nutrients, water, and oxygen. 
The skin acts as a barrier against the substances (apart from 
special elements such as oxygen for the retina and UV rays 
for vitamin D synthesis).18–21
Nano-sized particles can enter and penetrate some organs 
such as the lungs, intestine, and skin. Some can penetrate 
into the deepest layers of the skin (dermis). Their penetration 
depends on their size and nanoparticle surface features. 
It must be noted that in vitro tests must be carried out on 
nanoparticle toxicity before in vivo tests are performed. 
Figure 1 shows the areas of the body that should not be 
penetrated by nanoparticles.
The digestive (gastrointestinal) tract has a close 
relationship with the environment. Materials come into 
the body through the mouth and all nutrition is exchanged 
there, apart from gas. The histology of these three organs in 
relation to other places is different. The skin surface area of 
the body, which has an area of about 2 m2 and a thickness of 
about 10 µm, is composed of keratin cells. These cells form 
a barrier against transmitting ions. The amount of penetration 
is related to organ, age, and other agents.20,21
Toxicity of nanoparticles
Knowledge of the toxicity effects of these small substances 
is limited, but is rapidly growing. Many studies have 
shown that some nanoparticles demonstrate toxicity in 
biological systems. Thus research in the internal and 
external environment is needed; external studies can 
direct the internal studies. Some researchers have shown 
that most of the nanoparticles can release active oxygen 
and cause oxidative stress and inflammation by the RES 
(reticoendothelial system). Acute toxicity resulting from 
nanoparticles has been investigated in the mouths of rats. 
The results indicate that toxicity depends on the size, 
coating, and chemical component of the nanoparticles. Also, 
the systemic effects of nanoparticles have been shown in 
different organs and tissues. The effects on inflammatory 
and immunological systems may include oxidative stress or 
Figure 1 Parts of the body that should not be penetrated by nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1120
Ai et al
pre-inflammatory cytotoxin activity in the lungs, liver, heart, 
and brain. The effects on the circulatory system can include 
prethrombosis effects and paradox effects on heart function. 
Genotoxicity, carcinogenicity, and teratogenicity may occur 
as a result of the effects of nanoparticles. Some nanoparticles 
could pass the blood–brain barrier and cause brain toxicity 
(Figure 2); of course more studies are required.22–24
Due to the high loading of nanoparticles, macromolecule 
absorption will increase, so that they can cross through 
the digestive tract. Because, for example, lectin is such an 
immunologic material for coating, it can be toxigenic and also 
cause inflammatory responses or digestive stimulation.25,26
Nanotitania toxicity
Donaldson et al have shown that very small metal particles 
cause more inflammation than larger inhaled particles. 
Although the role of nanoparticles in toxicity is obscure, 
experimental evidence has shown that very small particles 
inhibit phagocytosis function more than larger particles.27 
Researchers have investigated the effects of nanoparticles 
on microorganisms, invertebrates, and vertebrates. There 
is motivation to do more studies on microorganisms due to 
their importance in industry and medicine. For example, the 
antimicrobial effects of some particles have increased their 
use in various consumer goods such as clothes and medical 
equipment. After extensive investigation, TiO2 nanoparticles 
were introduced as antimicrobial particles and can be used 
as a coating material for medical equipment, because of 
their antimicrobial and mechanical properties. TiO2 can 
accumulate some types of oxygen, the same as hydroxyl 
radicals and hydrogen peroxide, which has been done by 
oxidation and restoration under light. The oxygen comes 
into contact with UV rays, then a photo catalyst produces 
antimicrobial features which kill all bacteria with endotoxins 
which, in turn, have side effects in organisms.25–29 For example, 
in 2005, Lee et al discovered the killing features of TiO2 
nanoparticles and carbon nanotubes on endospore bacteria, 
which were coated with multi-wall nanotubes. He found 
that combining UV radiation with TiO2 is more effective, 
although the combined TiO2 and nanotubes caused endospore 
concentration. Therefore, some spores survived because of 
this protection.30 The toxic effect of metal oxide particles on 
marine fibroblasts and marine monocytic macrophages have 
been investigated. The particles were added to cells and the 
comparative plating effect was assembled after 6 to 8 days, 
depending on cell type. The results showed that the toxicity 
of ZrO2 and Al2O3 particles (d = 500–700 nm) increases more 
than TiO2 particles (130–180 nm). Al2O3 coated with TiO2 
particles have shown the same toxic effects. Dendritic TiO2 
has shown higher toxicity than other forms. The toxicity of 
ionic metals and other chemical materials differs among 
cells. The larger particles tend to show greater toxicity than 
the smaller particles. For example, the larger TiO2 particles 
cause a higher prevalence of the H-thymidine component than 
human monotypic macrophages. ZnO nanoparticles with a 
diameter of 500 to 3000 nm were placed on human fibroblasts 
for 24 hours. They were stained by hematoxin/eosin, which 
showed the extent of toxicity; the dead cells, which had been 
separated from the bottom of the glass, were not colored and 
the living cells still adhered and absorbed color. A digitizer 
was used to estimate the colored zone. The cells exposed to 
Al2O3, TiO2, Fe2O3, Fe3O4, CO2O3, NiO, Ga2O3, SnO, SnO2, 
and HgO, showed no toxic effect. The results acquired from 
studies on ZnO, CuO, Cu2O, Cr2O3, and Ag2O show that these 
particles have toxic effects.31
Silver
The antimicrobial effect of silver-coated surfaces has been 
studied with 16 types of bacteria. Silver nanoparticles are 
used in medical design, especially in dentistry. For example, 
nanosilver crystals are used in bandags as antimicrobial 
agents, but the use of silver nanoparticles depends on 
counteracting their positive (antimicrobial effect) and 
negative (cellular toxicity) effects. In one study, it was 
observed that nanosilver (12 nm) kills E scherichia coli. 
Figure 3 shows the effects of silver nanoparticles on bacteria 
by SEM analysis.32–35
Zinc oxide (ZnO) nanoparticles
ZnO acts as an effective UV filter when used in suncreams 
and textiles.36 Some animal studies and autoradiography have 
Figure 2 The passage of nanoparticles (NPs) from the nose to the cerebral system 
via the cibriform plate, which separates the nasal sinus from the brain and protects 
the nasal nerves and nervous receptors.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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shown that ZnO nanoparticles penetrate into the skin of rats 
and rabbits. Particles with a diameter of 50 to 100 nm can 
penetrate the skin because of the intracellular space of the 
corneum stratum, which is about 100 nm and the distance 
between the two layers is 0.5 to 1 nm. During inhalation, 
the particles enter the deep zones of the lung where they 
are surrounded and excluded by macrophages before 
epithelial damage. The particles can attach to the epithelium 
(causing inflammation) and the entrance to the interstitium 
where they have chronic effects on cells and have the ability 
to move to the lymphatic nodes.37,38
Fullerene toxicity
C60 was first discovered by Korto in 1985, who said that C60 
has 20 dimensions in different situations and is composed of 
apexes and 20 faces.39 Some features of C60 show that it has 
potential for use. For example, the first use of C60 has been 
in optics and conductors. Also, it is used to produce various 
sanitary products such as creams. Research has proved 
the antioxidative properties of C60.40 For instance, Wang 
suggested in 1999 that some C60 parasynthetics dissolved in 
water can inhibit lipid oxidation and radicalization and super 
oxidation.41 The risks of C60 particles were detected for every 
three groups of cells if the density was more than 50 ppb. 
The C60 particles affect the cellular membrane due to the 
induced peroxyl free radicals. Conversely, L-ascorbic acid 
inhibits risk and membrane damage. Some ecotoxicology 
research has shown that THF is a suitable solution for C60 
spreading, but the important point is that THF may change 
toxicity risk in particles, although more information is 
required.42 In 1998, Kamat et al described lipid oxidativity 
by C60 using the microorganisms of the liver. The study 
showed that changed fullerene can be toxic, but this toxicity 
depends on its group factors, which is not a feature of 
fullerene.43 Fullerenes can be used in drug delivery systems. 
The preparation methods for fullerene solution are very 
important. To prepare this solution, fullerene must first be 
dissolved in polar solvent, which is able to be dissolved 
in water. For example, scientists use tetrahydrofuran. The 
quick separation of organic solvent from aqueous fullerene 
solution is impossible. In fact, watery solution causes 
toxicity. In one new study, the researchers investigated 
the effects of these materials on fish, and described the 
fullerene antioxidative effect. Cerebral damage could 
occur due to respiratory medicines such as D-ethyl ether. 
Tetrahydrofuran has an ether-like effect and is very toxic. In 
fact, tetrahydrofuran caused cerebral damage, but fullerene 
had no such effects.44
Carbon nanotubes
Carbon nanotubes have a seamless graphite cylinder, 
which has featured in a number of studies, especially in 
medical science, it is also interesting to study because of 
its paradoxical effect on the body. Nanotubes can be made 
impure by other metals such as iron and initiate the redox 
cycle and ROS gathering (the same as asbestosis).45,46  
Carbon nanotubes may have numerous or single walls. 
Other structures are nanowires, nanorods, and nanosprings. 
We consider that the nanoparticles can be compressed, but 
nanotubes such as nanoropes, which are special nanotubes, 
can rotate around each other and make a larger fiber. Carbon 
nanotubes tend to twist in the form of a rope, which can 
be a problem (especially in the lungs).49 Nanotubes are 
structures that may behave as nanoparticles or fibers.41 For 
example, lung toxicity will occur at high doses of single- 
or multiple-wall carbons, but if their amount and dose are 
low, inflammation will occur in the lungs. Results have 
shown that carbon nanotubes at high dose are toxic for 
organisms, and accordingly, health scientists have defined 
them as dangerous and suggested manipulation of the 
nanoparticles.47 Also, an increase in the functional degree 
of single-wall carbon nanotubes displays lower toxicity 
than multi-wall nanotubes in in vitro tests on fibroblasts. 
Naturally, carbon nanotubes have an unchangeable and 
inactive surface. The length of time needed for the detection 
of toxicity in carbon nanotubes is still under study. Carbon 
nanotubes with a single wall are shorter and, if multi-walled, 
are about 100 nm long. In this context, we can mention 
the asbestosis because the length of those nanofibers are 
similar. In fact, some of the carbon nanotubes seem to be 
changeable and have the ability to rotate. Nanotubes can 
have fibrogenic effects such as big granulomas, which have 
been tested in rodents. Pleural mesothelioma is a cancer 
caused by asbestos exposure, yet rarely occurs in animals. 
Although these experiments are slow, nanotubes can be 
changed into larger particles by rotation, which gives us 
abnormal results.48–51 One way to reduce the toxicity of carbon 
Figure  3  Antibacterial  effect  (Escherichia  coli)  of  silver  nanoparticles  and  silver 
particles (control) over 24 hours.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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nanotubes is coating or functionalization. Functionalization 
can affect the properties of the carbon nanotubes, especially 
their toxicity.52
Nanodiamond particles
Biological contacts may be tolerated well by the body, but small, 
divided particles of these materials may cause carcinogenic 
effects.53 The variation in size of the particles influences the 
histological reaction and cytosine production.53,54
Diamond dust does not stimulate the active oxygen 
metabolite by polymorphonuclear (PMN) leukocytes 
(a clear path to chronic inflammation and lung tissue   
damage).
Twenty-one percent of PMN cells of 3-µm diamond-dust 
crystals at a viscosity of 2 mg/cm3 were phagocytized after 
45 minutes, but did not cause any chemotactic activity.55 In this 
study,55 horse and pig neutrophils were exposed to urea, apatite 
hydroxyl, and pyrophosphate. The results demonstrated that 
they induced superoxide and peroxide at the same viscosity 
and temperature, but exposing the neutrophils to the diamond 
crystal did not cause this effect at 37°C. The hydroxyapatite 
crystals stimulate some enzymatic reactions and the production 
of crude mitochondrial fractions (CMF). Hydroxyapatite 
(HA) particles usually have scaly surfaces with negative 
surface load (or zeta potential), but diamond particles are flat 
with low surface load or without load. Diamond is accepted in 
the scientific community as a biomaterial in the 21st century 
and is used in coatings for synthetic heart valves, orthopathy 
designs, joint substitutes, catheters, stent ortheopathic pins, 
and tooth roots. Figure 4 shows diamond nanoparticle coating 
on a hip implant, which will increase strength, but the release 
of nanoparticles as a result of scratching or abrasion can cause 
problems for the body. In vitro experiments with orthopathic 
pain coated by diamond-like carbon (DLC) implanted in sheep 
showed the low bioactivity of diamonds. Subconium implants 
coated with DLC in mice tibia for 30 days showed good 
osteogenesis in relation to the tissue implant. It is suggested 
that diamond coatings (during the chemical vaporization 
sedimentation process) used in artificial joints, stimulate the 
lower immune system (immune reactivity) and in vitro tests 
have shown that diamond abraded the releasing particles. 
The toxicity study of DLC coated nanoparticles on vicinity 
rust-proof steel implants in the hip shows good cell adhesion 
(human fibroblasts) and bioadjustment, and in vivo tests of 
rust-proof steel covered with DLC with 4 mm-cylinders 
implanted into cortical bone and sheep myometrical tissue 
did not appear to cause any problems. Chrome–cobalt 
cylinders coated with DLC were implanted in the muscle 
of rats: all implants showed good adjustment 90 days after 
the tests. Therefore, DLC covers are bioadjusted in both 
in vitro and in vivo environments of skeletal myometrical 
systems. Other DLC covers for osteoplants also show good 
bioadjustment. In most cases, erosion on Amorph diamond 
in comparison with commonly used material in the hip joint 
is immaterial. The carbon and diamond particles cultured 
by macrophages are digested without harmful effects. For 
example, the cells, which were exposed to a large amount of 
diamond dust, show recovery in less than 30 hours. The small 
particles of HA, silicon carbide, polymethylmethacrylate, 
and flouted diamonds in culture media, were compared 
with human serum monocytes at 0.5 mg/cm3 viscosity. The 
monocyte morphology changed after silicon carbide and 
HA digestion, but no differences were seen after diamond   
absorption.55
Magnetic nanoparticles
Iron oxide nanoparticles are applied in biological detection 
and treatment.56,57 Magnetic nanoparticles have been used 
in photogene, targeting drug delivery, cell separation, 
cancer therapy, imaging, and magnetic hyperthermia for 
cancer therapy, and also for tissue engineering. Bioadjusted 
super paramagnetic nanoparticles, 2 to 30 nm, with citric 
acid or methyl carboxyl dextrin were tested on rats and 
showed that these nanoparticles cause diarrhea and may 
lead to animal death while citrate itself does not cause 
toxicity.56–58 Of course, it is not clear whether the harmful 
agent was manganese, iron, or neither of these. The 
effects of bioadjusted coating layers have been studied on 
magnetic nanoparticles. Bovine serum albumin (BSA), 
poly-L-lactic acid (PLLA), and/or poly-ε-caprolactone 
were coated with eight nanometric particles. The toxicity 
reduction in human fibroblast cells was reported with super 
paramagnetic particles coated with pullulan. Uncoated 
iron oxide particles of 20 nm cause toxicity in human 
skin fibroblasts. Iron oxide nanoparticles of 9 nm were 
Figure 4 The implants with covers as nano diamond particles show better resistance 
and consistency.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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coated with polyvinyl alcohols (PVA), which have thiol, 
amine, and carboxylic acid functional groups. The results 
show that PVA nanoparticles, when combined with thiol, 
carboxyl, and PVA, poison melanoma cells. Higher levels 
of toxicity were seen in PVA nanoparticles combined with 
amine groups, especially when they are at high viscosity. 
Therefore, amino groups increase absorption into cells. 
Also, iron oxide nanoparticles coated with 9 nm citrate 
were studied on rat macrophages. NMR studies and atomic 
absorption have shown that the increased absorption of 
nanoparticles can easily be seen by a confocal microscope 
(iron oxide particles were marked with green rudimin 
and were exposed to the cells for 90 minutes at 37°C). 
After 1 day, the adhesive cells could be distinguished 
by their fluorescent color, which is the standard color 
for these studies (extracellular membrane structures). 
After 45 minutes of overlapping, the cells were washed 
and studied with a confocal microscope. With 488-nm 
optic aggravation, both green rudimin suffusions and red 
ANEPPS suffusions were monitored simultaneously. The 
results show that the iron oxide nanoparticles were absorbed 
by the cells. The high level of fluorescence of ANEPPS in 
the same zone causes this orientation, that is, iron oxide 
nanoparticles are concentrated in coated membrane 
vesicles. The cell lyses occur after exposing them for 
different lengths of time. During the short overlapping 
times, there was a distinctive increase in cell oxidation and 
MDA. Therefore, oxidative stress is temporary and the 
cells keep their functionality and could be useful for 
magnetic uses. We can see the relevance of another type 
of nanoparticle for the body’s immune system in super 
paramagnetic heating for terminating carcinomatous cells 
using iron oxide magnetic particles and their composites. 
The systemic temperatures can be created by a low dose of 
iron oxide. In clinical use, the iron oxides are absorbed by 
the reticuloendothelial system. Even if the iron particles 
surround the tumor environment, certain systemic risks 
can harm the reticuloendothelial system by heating the 
particle. The amount and effect of heating resulting from 
the iron oxide nanoparticles differ. We can see peculiar 
magnetic features and greater improvement because of the 
magnetic cross section, which depends on the component 
conjugated with nanoparticles. Nanoparticles activate 
the complementary system, which is a normal response 
of the immune system to external materials. In this 
system, the absorption of plasma protein on the surface 
of nanoparticles causes their detection, clearance, and 
digestion by RES system macrophages.59
Nanomaterial toxicity in drug delivery 
systems
Nanostructures can be used to transmit drug targets (as 
a drug or transmitter) or increase drug effectiveness.60 
Nanotechnology is important, especially for detecting 
and treating cancer, although many problems have yet 
to be solved. Essentially, nanostructures are studied for 
gene transmission and their usage in vaccination and 
cancer treatment. Gene transmitting has been done both 
in vitro and in vivo with different types of nanoparticles. 
In nanoparticle distribution in the body, immunological, 
pathological, pharmacological, and pharmacodynamic fac-
tors (time-base level of absorption, metabolism, and drug 
clearance) control the distribution of biological behaviors 
of nanoparticles in the body. In an in vivo environment, 
the fate of nanoparticles depends on these factors. After 
intravenous effusion of nanoparticles on rats, nanopar-
ticles were rapidly removed from the blood. This action 
was done by the immune and reticuloendothelial system 
without considering the particle features. Autoradio-
graphic studies have shown that nanoparticles are usually 
concentrated in the liver and bone marrow. Cyanoacrylic 
polymeric nanoballs decrease gradually in the liver and are 
cleared from the body in the feces and urine.61–63 Nanoball 
clearance was completed after 7 days. Briefly, we can say 
that the liver is an important organ for the clearance of 
nanoparticles. The highest concentration of nanoparticles 
is found in liver cells. On the other hand, the concentra-
tion of these particles on mononuclear phagocytes causes 
the drug to keep away from the target cells. We suggest 
several methods for preventing this event. One is magnetic 
directional guidance of intravenous particles out of the 
body. It seems that this effect is intensified by increasing 
tumor angiogenesis. For example, albumin microballs 
with magnetic characteristics containing doxorubicin can 
penetrate into tumors more effectively than  free drugs. 
On the other hand, by using nanoparticles to introduce 
the drugs into the body, drug distribution coincides with 
particle distribution. Changing the distribution model for 
nanoparticles is useful for some diseases such as cancer 
and also for reduction in drug toxicity. This advice has 
been used for anticarcinoma drugs and doxorubicin. The 
use of this drug has been limited because of chronic and 
acute cardiac failure. Doxorubicin nanoballs have lower 
toxicity than free drugs. Using this method, it is possible 
to transmit drugs into the MPS system with mononuclear 
phagocytes. Researchers have detected that ampicillin 
density in the liver is 20 times more than when free drugs International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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are used. Intramuscular injection of labeled polymethyl 
methacrylate nanoparticles showed that these particles were 
fully absorbed after 70 days. After subcutaneous injection, 
the concentration of the nanoparticles decrease slowly 
in the tissues. Moreover, the injection of nanoparticles 
causes better performance in drug delivery systems, which 
results in increased bioavailability of peptic drugs after 
the drug injection has metabolized freely. As research has 
shown, nanoparticles are picked up on a large scale by 
mononuclear phagocytes after intravenous injection. On 
the other hand, it has been proved that distribution in the 
body can affect nanoparticle toxicity. Thus, in a new drug 
transmission system based on polymers, we must consider 
the possibility of activation or inhibition of mononuclear 
phagocytes. In this case, we must pay attention to changes 
in blood viscosity because the clot could be composed of 
nanoparticles and could cause red blood cell destruction. 
For other prescription methods, such as from the skin or 
through oral means, the stimulation of the local tissue is 
important.64–66
One of the problems of using nanoparticles in pharmacology 
is their uptake by the mononuclear phagocytosis system as 
they exist in the liver and spleen, although the targeting of 
the liver by nanoparticles may be suitable during treatment 
of liver diseases such as turmeric metastasis or hepatitis. 
Oligonucleotides can be used to control gene expression when 
they migrate to the liver when bonded with biodestructible 
polyalkyl cyanoacrylate nanoparticles. Besides the reduction 
in treatment effect, the uptake of nanoparticles in the liver 
may have a negative effect on liver function. The inflammatory 
responses by glycoprotein acid diffusion were caused by 
hepatocytes.67
Although nanoformulations for nanotransmission 
is increasingly proposed without any reduction in drug 
activity, in one study, insulin-cytosine nanoparticles were 
compared with cytosine solution and cytosine powder 
formulation. Insulin-cytosine nanoparticles showed a 
decreasing effect in viability and blood sugar in both mouse 
and sheep models. In pharmacology, the organs or cells 
are equally important, but nanoparticle effects on cells 
are important. For encapsulated drug activity, releasing 
of intracellular fluid is required; however, cell absorption 
for nanoparticles that are 20 nm or less in size do not 
need the endocytic mechanism. Chemical features such as 
surface load may affect intracellular nanoparticles. PLGA 
nanoparticles are digested by cells during endocytosis. One 
of the effects of nanoparticle formulation is an increase in 
cell encapsulation. Use of nanoparticles as drug transmitters   
may reduce combined drug toxicity. Usually, drug toxicity 
profiles are studied extensively while nanoparticle results 
are not described. Therefore, we cannot differentiate 
between nanoparticle and drug toxicity. In vitro toxicity 
is decreased (when compared with free indometacin) for 
nanospheres loaded with indometacin (at sizes smaller 
than 200 nm) combined with polymethoxy polymers 
(ethylene glycol/poly[ε-caprolacton]). However, toxicity 
in nanopolymers are yet to be profiled. Based on in vitro 
acute toxicity studies, LD50 was 1.47 g/kg, and 50% of 
LD50 tested for 7 days  did not induce toxicity in the heart, 
lung, liver, or kidney, whereas it was detected 8 days after 
treatment and usage. Quantum dots of 15–20 nm show that 
these particles migrate and concentrate in lymphatic nodes 
around the injection zone. Nanoparticles can be injected in 
veins in a colloid drug releasing system. They can also be 
injected in the muscle or used in oral or optical applications. 
With intravenous injections, quantum dots move to the 
reticuloendothelial system (RES), which releases them into 
the liver, spleen, brain, bone, and also cardiac, renal, and 
respiratory systems. This distribution changes when the 
hydrophobicity and the surface load are corrected with the 
nanoparticle covers on different surfaces (same as surface 
correction with PEG and poloxamer). The nanoparticles 
are largely removed by mononuclear phagocytes after 
intravenous injection. On the other hand, it has been proved 
that the nano distribution model in the body can affect 
its toxicity. In fact, changing the drug distribution and 
pharmacokinetics could help develop a new model for drug 
effect and metabolism.67 For example, doxorubicin cardiac 
and bone toxicity may be increased after combing this drug 
with smaller nanoparticles. Accordingly, in a novel drug 
transmission system based on polymers, we must consider 
the possibility of mononuclear phagocyte activation or 
inhibition. For example, with changing nanosuspension 
surface features, their effects can be improved even 
more. Nanoparticle adhesion is an important factor in 
bioapplication, drug absorption, and reduction of drug 
clearance. Therefore, using mucus on nanoparticle surfaces 
can improve drug absorption.67,68
Nanomaterial toxicity mechanism  
for drug delivery in cancer therapy
As mentioned before, one of the advantages of using 
nanoparticles in drug formulations is their potential for 
crossing the blood–brain barrier, although this function 
could have harmful effects. The nanoparticles have a toxic 
effect on cerebral endothelium cells. Of course, this is not International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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true when applied to all nanoparticles of the same size. 
The physical features of biological materials and their 
ability to adhere to nanoparticles are important. When 
nanoparticles with different surface features are tested, 
neutral nanoparticles and anionic nanoparticles do not have 
any effect on the blood cerebral system, while a high density 
of cationic nanoparticles has toxic effects on the blood–brain 
barrier system. The surface load of nanoparticles must be 
considered with regard to their toxicity effect and cerebral 
distribution profiles. The nanoparticles cause material 
transmission into the brain via the polysorbate surfactant 
Tween. The transmission mechanism by endocytosis of 
lipoprotein receptors at low density of endothelial cells after 
the absorption of blood plasma lipoprotein with nanoparticles 
is suggested.70,71
The effect of paclitaxel entrapment and toxic drug effects 
in polysorbate/steel alcohol nanoparticles was studied in rats 
in a cerebral injection model. The results show that paclitaxel 
entrapment in nanoparticles clearly increases cerebral drug 
absorption and its toxicity in tumor cell P-glycoprotein 
expression.72
After oral injection, only 10% of 60 nm polystyrene 
particles were recovered again from the digestive tract. Most 
of these particles were found in the lymphatic tissue, such 
as Peyer’s patches and the lymphatic tissues in the colon. 
The injection of nanoparticles in the dermis is optimal for 
cationic particles in the size range of 50 to 500 nm, and 
less effective with anionic and neutral particles of any size. 
Migration to the draining lymphatic nodes is important 
for detection and treatment. Polyisobutyl cyanoacrylate 
nanoparticle formulation and fluorescent quantum dots are 
found entrapped in the draining lymphatic nodes.72
The structures and features of nanogold particles make 
them useful for estimating their biological use. Although 
some of the effects were seen by using these systems 
at high density, using 2 nm gold cationic particles in 
microbiological estimates and in vitro hemolysis show 
slight toxicity. Since the anionic particles are comparatively 
nontoxic, these very small 2 nm gold nanoparticles are 
nontoxic when they are  used in rats for tumor treatment.73–75 
If we compare free TNF with PEG colloidal nanoparticles 
conjugated with TNF we observe increasingly antitumoral 
activity. While the best isomer inhibitors of topoisomerase 
are formulated in nanoparticle lipid, its antitumoral activity 
will increase in the in vivo model of human tumors grown 
on rat glands.76
Conclusion
In this review article, nanobiomaterials, which are used 
in the field of medical science, have been discussed and 
their toxicity effects investigated. It is obvious that most 
nondegradable nanoparticles considered in this review are 
toxic and can influence the body’s cells. The biocompatible 
coatings improve the performance of these nanoparticles, 
reduce their toxicity, and do not result in negative effects on 
cells. The emphasis of this study is to use biodegradable and 
biocompatible nanobiomaterials. Some synthetic materials 
such as PLGA, PCL, or natural materials such as collagen or 
chitosan can themselves be used as nanoparticles in medical 
applications.
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